CDKN2A and neoplasm: The inactivation of CDKN2A by homozygous deletions, loss of single allele combined with intragenic mutation in the second allele, or hypermethylation of the promoter, causes the functional deactivation of the p16 protein and, consequently, increased cell proliferation, contributing to tumor formation and growth (8, 14).